|
1
|
Donahue SL and Campbell C: A DNA double
strand break repair defect in Fanconi anemia fibroblasts. J Biol
Chem. 277:46243–46247. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Donahue SL, Lundberg R, Saplis R and
Campbell C: Deficient regulation of DNA double-strand break repair
in Fanconi anemia fibroblasts. J Biol Chem. 278:29487–29495. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Epanchintsev A, Shyamsunder P, Verma RS
and Lyakhovich A: IL-6, IL-8, MMP-2, MMP-9 are overexpressed in
Fanconi anemia cells through a NF-κB/TNF-α dependent mechanism. Mol
Carcinog. 54:1686–1699. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ibáñez A, Río P, Casado JA, Bueren JA,
Fernández-Luna JL and Pipaón C: Elevated levels of IL-1β in Fanconi
anaemia group A patients due to a constitutively active
phosphoinositide 3-kinase-Akt pathway are capable of promoting
tumour cell proliferation. Biochem J. 422:161–170. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liotta LA, Tryggvason K, Garbisa S, Hart
I, Foltz CM and Shafie S: Metastatic potential correlates with
enzymatic degradation of basement membrane collagen. Nature.
284:67–68. 1980. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis, and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
|
|
7
|
Stetler-Stevenson WG: Type IV collagenases
in tumor invasion and metastasis. Cancer Metastasis Rev. 9:289–303.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sato T, Sakai T, Noguchi Y, Takita M,
Hirakawa S and Ito A: Tumor-stromal cell contact promotes invasion
of human uterine cervical carcinoma cells by augmenting the
expression and activation of stromal matrix metalloproteinases.
Gynecol Oncol. 92:47–56. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Pyke C, Kristensen P, Ralfkiaer E,
Grøndahl-Hansen J, Eriksen J, Blasi F and Danø K: Urokinase-type
plasminogen activator is expressed in stromal cells and its
receptor in cancer cells at invasive foci in human colon
adenocarcinomas. Am J Pathol. 138:1059–1067. 1991.PubMed/NCBI
|
|
10
|
Vincenti MP, White LA, Schroen DJ, Benbow
U and Brinckerhoff CE: Regulating expression of the gene for matrix
metalloproteinase-1 (collagenase): Mechanisms that control enzyme
activity, transcription and mRNA stability. Crit Rev Eukaryot Gene
Expr. 6:391–411. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ray JM and Stetler-Stevenson WG: The role
of matrix metalloproteases and their inhibitors in tumour invasion,
metastasis and angiogenesis. Eur Respir J. 7:2062–2072.
1994.PubMed/NCBI
|
|
12
|
Apodaca G, Rutka JT, Bouhana K, Berens ME,
Giblin JR, Rosenblum ML, McKerrow JH and Banda MJ: Expression of
metalloproteinases and metalloproteinase inhibitors by fetal
astrocytes and glioma cells. Cancer Res. 50:2322–2329.
1990.PubMed/NCBI
|
|
13
|
Niedzwiecki A, Roomi MW, Kalinovsky T and
Rath M: Micronutrient synergy - a new tool in effective control of
metastasis and other key mechanisms of cancer. Cancer Metastasis
Rev. 29:529–542. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: Comparative effects of EGCG, green tea and a
nutrient mixture on the patterns of MMP-2 and MMP-9 expression in
cancer cell lines. Oncol Rep. 24:747–757. 2010.PubMed/NCBI
|
|
15
|
Rath M and Pauling L: Plasmin-induced
proteolysis and the role of apoprotein(a), lysine and synthetic
analogs. Orthomolecular Med. 7:17–23. 1992.
|
|
16
|
Sun Z, Chen YH, Wang P, Zhang J, Gurewich
V, Zhang P and Liu JN: The blockage of the high-affinity lysine
binding sites of plasminogen by EACA significantly inhibits
prourokinase-induced plasminogen activation. Biochim Biophys Acta.
1596:182–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Valcic S, Timmermann BN, Alberts DS,
Wächter GA, Krutzsch M, Wymer J and Guillén JM: Inhibitory effect
of six green tea catechins and caffeine on the growth of four
selected human tumor cell lines. Anticancer Drugs. 7:461–468. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Mukhtar H and Ahmad N: Tea polyphenols:
Prevention of cancer and optimizing health. Am J Clin Nutr. 71
Suppl 6:1698S–1704S. 2000.PubMed/NCBI
|
|
19
|
Yang GY, Liao J, Kim K, Yurkow EJ and Yang
CS: Inhibition of growth and induction of apoptosis in human cancer
cell lines by tea polyphenols. Carcinogenesis. 19:611–616. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Taniguchi S, Fujiki H, Kobayashi H, Go H,
Miyado K, Sadano H and Shimokawa R: Effect of (−)-epigallocatechin
gallate, the main constituent of green tea, on lung metastasis with
mouse B16 melanoma cell lines. Cancer Lett. 65:51–54. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hara Y: Green tea: Health Benefits and
Applications. Marcel Dekker; New York, Basel: 2001, http://dx.doi.org/10.1201/9780203907993
View Article : Google Scholar
|
|
22
|
Kawakami S, Kageyama Y, Fujii Y, Kihara K
and Oshima H: Inhibitory effect of N-acetylcysteine on invasion and
MMP-9 production of T24 human bladder cancer cells. Anticancer Res.
21:213–219. 2001.PubMed/NCBI
|
|
23
|
Morini M, Cai T, Aluigi Mg, Noonan DM,
Masiello L, De Flora S, D'Agostini F, Albini A and Fassina G: The
role of the thiol N-acetylcysteine in the prevention of tumor
invasion and angiogenesis. Int J Biol markers. 14:268–271.
1999.PubMed/NCBI
|
|
24
|
Yoon SO, Kim MM and Chung AS: Inhibitory
effect of selenite on invasion of HT1080 tumor cells. J Biol Chem.
276:20085–20092. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cha J, Roomi MW, Ivanov V, Kalinovsky T,
Niedzwiecki A and Rath M: Ascorbate supplementation inhibits growth
and metastasis of B16FO melanoma and 4T1 breast cancer cells in
vitamin C-deficient mice. Int J Oncol. 42:55–64. 2013.PubMed/NCBI
|
|
26
|
Naidu KA, Karl RC, Naidu KA and Coppola D:
Antiproliferative and proapoptotic effect of ascorbyl stearate in
human pancreatic cancer cells: Association with decreased
expression of insulin-like growth factor 1 receptor. Dig Dis Sci.
48:230–237. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Anthony HM and Schorah CJ: Severe
hypovitaminosis C in lung-cancer patients: The utilization of
vitamin C in surgical repair and lymphocyte-related host
resistance. Br J Cancer. 46:354–367. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Maramag C, Menon M, Balaji KC, Reddy PG
and Laxmanan S: Effect of vitamin C on prostate cancer cells in
vitro: Effect on cell number, viability, and DNA synthesis.
Prostate. 32:188–195. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Koh WS, Lee SJ, Lee H, Park C, Park MH,
Kim WS, Yoon SS, Park K, Hong SI, Chung MH, et al: Differential
effects and transport kinetics of ascorbate derivatives in leukemic
cell lines. Anticancer Res. 18:2487–2493. 1998.PubMed/NCBI
|
|
30
|
Chen Q, Espey Mg, Krishna MC, Mitchell JB,
Corpe CP, Buettner GR, Shacter E and Levine M: Pharmacologic
ascorbic acid concentrations selectively kill cancer cells: Action
as a pro-drug to deliver hydrogen peroxide to tissues. Proc Natl
Acad Sci USA. 102:13604–13609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Núñez M, Artín C and de Apodaca y Ruiz A
Ortiz: Ascorbic acid in the plasma and blood cells of women with
breast cancer. The effect of the consumption of food with an
elevated content of this vitamin. Nutr Hosp. 10:368–372. 1995.(In
Spanish). PubMed/NCBI
|
|
32
|
Kurbacher CM, Wagner U, Kolster B,
Andreotti PE, Krebs D and Bruckner HW: Ascorbic acid (vitamin C)
improves the antineoplastic activity of doxorubicin, cisplatin, and
paclitaxel in human breast carcinoma cells in vitro. Cancer Lett.
103:183–189. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cooke JP and Dzau VJ: Nitric oxide
synthase: Role in the genesis of vascular disease. Annu Rev Med.
48:489–509. 1997. View Article : Google Scholar : PubMed/NCBI
|
